Altogether, the obtained data strongly suggest that the correct TRPV1 modulation can improve CCl4-induced hepatic fibrosis and attenuate the effect of TGF-β on HSC activation and proliferation. This evidence concerns the gene TRPV1 and Hepatic fibrosis.